Cardiometabolic Health,
Redefined for Women.

Identifying and treating early risk—before it becomes disease.

Built on cardiology-based evaluation, advanced biomarkers, and targeted intervention

This is not a wellness or coaching model.

AthenaVita is a clinical prevention program focused on early cardiometabolic risk—before traditional disease thresholds are met.

Most women are told they’re “fine” based on standard labs.
But normal does not always mean low risk.

We evaluate where your physiology is heading over the next 10–20 years—and intervene early to change that trajectory.

The AthenaVita Framework

Clinical, structured, and measurable.

Inside AthenaVita, you can expect a structured, clinical approach to cardiometabolic prevention.

Cinical Intake + Risk Identification
Comprehensive history, risk factors, and baseline assessment
Advanced cardiometabolic lab evaluation
Including ApoB, Lp(a), metabolic and inflammation markers
Risk + Trajectory Assessment
Understanding where your physiology is heading—not just where it is today
Clinical Intervention Strategy
Integration of nutrition and strength training to preserve and build metabolic health
Longitudinal Monitoring + Adjustment
Repeat labs, track response, and refine your plan over time

When appropriate, this may also include coordination of care, referrals, or medical therapy.

Is AthenaVita Right for You

AthenaVita is designed for women who:

Want a clinical understanding of their long-term health risk
Have been told they are “fine,” but know something isn’t adding up
Are in their 30s–50s navigating metabolic or hormonal shifts
Value structured, high-touch, medically informed care

This is not:

A general wellness or coaching program
A quick weight loss solution
A substitute for primary care, urgent medical care, or established specialists.

This is a focused, clinical approach to long-term cardiometabolic prevention.

About the Founder

Kate Freeman is a board-certified nurse practitioner specializing in cardiovascular care and electrophysiology, with over a decade of experience managing complex cardiac patients across both inpatient and outpatient settings.

Her clinical work has centered on the diagnosis, monitoring, and longitudinal management of cardiovascular disease.

This depth of experience exposed a consistent limitation in traditional care: risk is typically addressed only after disease is established, rather than when early physiologic changes first begin to emerge.

AthenaVita was developed to close that gap.

AthenaVita is a clinically grounded model focused on early risk identification, advanced lab interpretation, and structured intervention—designed to assess and redirect cardiometabolic trajectory before the onset of disease. Her approach is built in physiology, data, and long-term risk modeling, not symptom-based care or generalized wellness strategies.

Her work is particularly focused on women in midlife, where shifts in metabolic and hormonal physiology accelerate cardiovascular risk—often years before it is detected in standard evaluations.

Kate Freeman practices in Arizona.

AthenaVita reflects a single clinical objective: identify risk early, intervene with precision, and change the trajectory before disease develops.

Your Questions, Answered

AthenaVita is a cardiometabolic prevention program for women.
It is designed for the phase before disease—when physiology is already shifting, but has not yet crossed a diagnostic threshold.
The focus is not on symptoms alone, or isolated lab values. It is on understanding patterns over time: how lipid markers, insulin dynamics, body composition, and hormonal transitions intersect to influence long-term risk.
This is a clinical, physiology-first model—applied earlier, with the goal of changing trajectory rather than reacting to it.
The founding cohort is a six-month clinical experience within AthenaVita.
It is intentionally limited in size to allow for greater depth, continuity, and individualized interpretation. Over time, patterns become clearer, shifts become measurable, and decisions more precise.
This is not episodic care.
It is a longitudinal process—designed to understand and influence your physiology over time.
AthenaVita is designed for women who have been told their labs are “normal,” but can feel that something has shifted.
Women who are already high-functioning in other areas of their life—and expect the same level of clarity and precision when it comes to their health.
Women who are not looking for generalized plans, but for a deeper understanding of what is actually happening in their body.
Women who are willing to invest in their long-term health—before it becomes something they have to manage later.
Most programs focus on symptoms, short-term outcomes, or generalized guidance.
AthenaVita is structured around clinical interpretation.
The same labs that are often labeled “normal” are evaluated differently—
in the context of long-term cardiovascular risk, metabolic function, and hormonal transition.
Markers such as lipid patterns, ApoB, Lp(a), insulin dynamics, and inflammatory markers are not viewed in isolation, but as part of a larger physiological pattern over time.
From there, nutrition, strength training, and other interventions are applied with intention—based on those findings, not as templates.
This is not a coaching model, and it is not a weight-loss program.
It is a clinical, prevention-focused approach for women who want to understand their physiology—and change the trajectory early.
The founding cohort is offered at a rate of $4,800 for the full six-month experience.
Payment may be completed upfront or structured as monthly installments of $800.
This reflects the level of clinical involvement and access built into the program. Pricing will evolve in future cohorts.
AthenaVita services may be eligible for reimbursement through Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA), depending on your individual plan.
We recommend confirming coverage directly with your provider. Documentation can be provided to support reimbursement if needed.
AthenaVita is designed to work alongside your existing medical care—not replace it.
Routine care, screening, and the management of established conditions should continue with your primary care provider or appropriate specialist.
Within AthenaVita, the focus is on earlier interpretation of cardiometabolic risk, identifying patterns before they meet criteria for disease, and building a structured approach to address them.
When indicated, further evaluation or management may be directed back to your primary care provider or appropriate specialist.
Each application is reviewed individually.
If there is alignment, we will reach out directly to discuss next steps and determine whether this is the right fit.